J Wiebel

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

Katherine R. Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani et al. · The Lancet · 2023 · 151 citations · Full text

Hypertension, Renal Function, Renal Disease +10

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 88 citations · Full text

Use of imaging tests after primary treatment of thyroid cancer in the United States: population based retrospective cohort study evaluating death and recurrence

Mousumi Banerjee, J Wiebel, Cui Guo et al. · BMJ · 2016 · 39 citations · Full text

ESTROGEN TREATMENT IN TALL GIRLS

Nicholas J. Kuhn, W Blunck, N Stahnke et al. · Acta Paediatrica · 1977 · 37 citations

CEREBELLAR‐ATAXIC SYNDROME IN CHILDREN AND ADOLESCENTS WITH HYPOTHYROIDISM UNDER TREATMENT

J Wiebel · Acta Paediatrica · 1976 · 22 citations

Quantitative Growth, Corticobasal Degeneration, Neurological Disorder +10